Medicine and Dentistry
Sickle-Cell Disease
100%
Occlusion
54%
Inflammation
43%
Transgenic Mouse
26%
Hemopexin
25%
Heme
25%
Endothelial Cell
22%
Embryonic Hemoglobin
17%
Erythrocyte
17%
Thromboplastin
17%
Cells
15%
Hydroxyurea
14%
Therapeutic Procedure
14%
Combination Therapy
13%
Hypoxia
13%
Plasma
13%
Hemoglobin
13%
Von Willebrand Factor
12%
Cell Activation
12%
Infusion
11%
Heme Oxygenase 1
11%
Endothelium
10%
Complement Activation
10%
Haptoglobin
9%
Oxidative Stress
9%
Toll Like Receptor 4
9%
Blood
9%
Nitric Oxide
9%
Leukocyte
8%
Transcription Factor Nrf2
8%
Carbon Monoxide
8%
Complement Component C5a
8%
Immunoglobulin Enhancer Binding Protein
8%
Hemolysis
8%
Therapeutic Agent
7%
Cell Adhesion
7%
Phosphodiesterase
7%
Endothelial Nitric Oxide Synthase
7%
Serine Proteinase
7%
Trichostatin A
7%
Anemia
7%
Histone Deacetylase Inhibitor
7%
Mononuclear Cell
7%
Coagulopathy
7%
Vorinostat
7%
PADGEM Protein
6%
Liver
6%
Vascular Cell Adhesion Molecule 1
5%
Monoclonal Antibody
5%
Patient
5%
Immunology and Microbiology
Sickle Cell
26%
Heme
17%
Cells
16%
Cell Activation
10%
TLR4
10%
Mouse
8%
Blood Plasma
8%
Hemocyte
8%
Inflammation
8%
Cell Adhesion
7%
Myeloid Differentiation
7%
Monoclonal Antibodies
7%
Complement Activation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Sickle Cell Anemia
23%
Inflammation
15%
Mouse
12%
Heme
11%
Occlusion
11%
Toll Like Receptor 4
8%
Fumaric Acid Dimethyl Ester
7%
Carbon Monoxide
7%
Anemia
7%